The Recall Desk
HighFDA (Devices)·Z-1230-2024·Announced 2024-03-13

VITROS 4600 Chemistry System Software Defect Affects Quality Control Reporting

A software defect in VITROS 4600 Chemistry Systems running software versions 3.8.0 or 3.8.1 prevents quality control rules from being flagged or reported correctly, potentially allowing erroneous patient results to be released.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: FDA Class II recall with no reported illnesses, injuries, or deaths. The defect creates risk of erroneous patient results through quality control reporting failures. Under the rubric, risk-of-harm products without reported injury are rated High (3).

Plain-English summary

A software defect in the VITROS 4600 Chemistry System affects units running software versions 3.8.0 or 3.8.1. The defect prevents the system's Configurable Westgard Rules—a quality control mechanism—from being flagged or reported when defined criteria are met.

When quality control rules are not properly reported, the system may accept and report quality control results that do not meet acceptance standards, potentially resulting in erroneous patient results being released to healthcare providers.

The recall affects 15 units in the United States and 43 units outside the United States, including Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Denmark, France, Germany, India, Italy, Japan, Mexico, Norway, Portugal, Russia, Singapore, Spain, Sweden, the Netherlands, and the United Kingdom.

The recalled product

Product
VITROS 4600 Chemistry System Catalog Nos. 6802445 (regular) and 6900440 (refurbished)
Manufacturer
Ortho-Clinical Diagnostics, Inc.
Hazard
  • software-defect
  • quality-control-failure
  • result-inaccuracy

Distribution

Distributed nationwide across the United States.